212 related articles for article (PubMed ID: 27225838)
1. Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans.
Nóbrega RO; Teixeira AP; Oliveira WA; Lima EO; Lima IO
Pharm Biol; 2016 Nov; 54(11):2591-2596. PubMed ID: 27225838
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity study of the monoterpene thymol against
Teixeira APC; Nóbrega RO; Lima EO; Araújo WO; Lima IO
Nat Prod Res; 2020 Sep; 34(18):2630-2633. PubMed ID: 30584769
[No Abstract] [Full Text] [Related]
3. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
Vardar-Unlu G; Yağmuroğlu A; Unlu M
Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
[TBL] [Abstract][Full Text] [Related]
4. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
5. Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis.
Pereira Fde O; Mendes JM; Lima IO; Mota KS; Oliveira WA; Lima Ede O
Pharm Biol; 2015 Feb; 53(2):228-34. PubMed ID: 25414073
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320
[TBL] [Abstract][Full Text] [Related]
7. [Determination of the minimum inhibitory concentration of fluconazole against Cryptococcus neoformans].
Fernández Andreu CM; Pimentel Turino T; Martínez Machín G; González Miranda M
Rev Cubana Med Trop; 1999; 51(1):55-7. PubMed ID: 10887558
[TBL] [Abstract][Full Text] [Related]
8. Fisetin as a promising antifungal agent against Cryptocococcus neoformans species complex.
Reis MP; Carvalho CR; Andrade FA; Fernandes OF; Arruda W; Silva MR
J Appl Microbiol; 2016 Aug; 121(2):373-9. PubMed ID: 27107205
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects and mechanism of antifungal action of the natural cyclic depsipeptide, aureobasidin A against Cryptococcus neoformans.
Teymuri M; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Bioorg Med Chem Lett; 2021 Jun; 41():128013. PubMed ID: 33811994
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Antifungal Mechanisms of Thymol in the Human Fungal Pathogen,
Jung KW; Chung MS; Bai HW; Chung BY; Lee S
Molecules; 2021 Jun; 26(11):. PubMed ID: 34200464
[TBL] [Abstract][Full Text] [Related]
12. Anti-Candida albicans effectiveness of citral and investigation of mode of action.
Lima IO; de Medeiros Nóbrega F; de Oliveira WA; de Oliveira Lima E; Albuquerque Menezes E; Cunha FA; Formiga Melo Diniz Mde F
Pharm Biol; 2012 Dec; 50(12):1536-41. PubMed ID: 23116193
[TBL] [Abstract][Full Text] [Related]
13. The "in vitro" antifungal activity evaluation of propolis G12 ethanol extract on Cryptococcus neoformans.
Fernandes FF; Dias AL; Ramos CL; Ikegaki M; de Siqueira AM; Franco MC
Rev Inst Med Trop Sao Paulo; 2007; 49(2):93-5. PubMed ID: 17505666
[TBL] [Abstract][Full Text] [Related]
14. Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi.
Abbaszadeh S; Sharifzadeh A; Shokri H; Khosravi AR; Abbaszadeh A
J Mycol Med; 2014 Jun; 24(2):e51-6. PubMed ID: 24582134
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyaldimines as potent in vitro anticryptococcal agents.
Magalhães TF; da Silva CM; de Fátima Â; da Silva DL; Modolo LV; Martins CV; Alves RB; Ruiz AL; Longato GB; de Carvalho JE; de Resende-Stoianoff MA
Lett Appl Microbiol; 2013 Aug; 57(2):137-43. PubMed ID: 23594040
[TBL] [Abstract][Full Text] [Related]
16. Endophytic fungal compounds active against Cryptococcus neoformans and C. gattii.
Pereira CB; de Oliveira DM; Hughes AF; Kohlhoff M; LA Vieira M; Martins Vaz AB; Ferreira MC; Carvalho CR; Rosa LH; Rosa CA; Alves TM; Zani CL; Johann S; Cota BB
J Antibiot (Tokyo); 2015 Jul; 68(7):436-44. PubMed ID: 25712396
[TBL] [Abstract][Full Text] [Related]
17. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
Vu K; Gelli A
Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
[TBL] [Abstract][Full Text] [Related]
18. Antifungal properties of essential oils and their main components upon Cryptococcus neoformans.
Viollon C; Chaumont JP
Mycopathologia; 1994 Dec; 128(3):151-3. PubMed ID: 7739729
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
20. Novel imidazo[2,1-b]-1,3,4-thiadiazoles as promising antifungal agents against clinical isolate of Cryptococcus neoformans.
Alwan WS; Karpoormath R; Palkar MB; Patel HM; Rane RA; Shaikh MS; Kajee A; Mlisana KP
Eur J Med Chem; 2015 May; 95():514-25. PubMed ID: 25847769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
